1 Solovic I, Sester M, Gomez-Reino JJ, et al. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J 2010; 36: 1185–1206. 2 Mack U, Migliori GB, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956–973. 3 Diel R, Goletti D, F...

COVID-19 infection not only profoundly impacts the detection of tuberculosis (Tbc) but also affects modality in patient immune response. It is important to determine response alterations latent as well SARS-CoV-2-infected patients. Such changes may have underlying effects on development and course further tuberculosis. Here, we aimed review characteristics TB patients or convalescent with (LTBI...

Tuberculosis guidelines identify individuals receiving the corticosteroid drug prednisone (or its equivalent) at a dose of .15 mg?day for 2–4 weeks or more as a group at risk of tuberculosis if infected with Mycobacterium tuberculosis [1, 2]. There is an eight-fold increased risk of developing active tuberculosis with such drugs at this dose [3]. However, there is no information on the epidemio...